[228 + Pages Report] According to a market research study published by Zion Market Research, the demand analysis of Global Cardiac Arrest Treatment Market size & share revenue was valued at around USD 5 billion in 2022 and is estimated to grow about USD 8.3 billion by 2030, at a CAGR of approximately 4.5% between 2023 and 2030. The key market players are listed in the report with their sales, revenues and strategies are Pfizer Inc., GE Healthcare, Novartis AG, Bayer AG, Boston Scientific Corporation, Amgen Inc., Abbott Laboratories, and others.
NEW YORK, United States, Oct. 02, 2023 (GLOBE NEWSWIRE) — Zion Market Research has published a new research report titled “Cardiac Arrest Treatment Market By Treatment (Drugs [Vasopressors, Anti-Arrhythmic Drugs, Anticholinergic Drugs, Corticosteroids, Fibrinolytic Drugs, Beta Blockers, And Others] And Medical Devices [Defibrillators, Cardiac Resynchronization Therapy, And Others)], By Distribution Channel (Hospitals, Pharmacies, And Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030” in its research database.
“According to the latest research study, the demand of global Cardiac Arrest Treatment Market size & share in terms of revenue was valued at USD 5 billion in 2022 and it is expected to surpass around USD 8.3 billion mark by 2030, growing at a compound annual growth rate (CAGR) of approximately 4.5% during the forecast period 2023 to 2030.”
What is Cardiac Arrest Treatment? How big is the Cardiac Arrest Treatment Industry?
Report Overview:
A sudden cessation of heartbeat is the defining characteristic of the medical emergency known as cardiac arrest. This happens when the demand for oxygen towards the heart does not exceed the requirement, which leads to the death of heart muscle cells and ultimately causes a heart attack. In addition to these causes, cardiac arrest can also be brought on by a number of other conditions, such as cardiomyopathy, coronary artery disease, Brugada syndrome, and long QT syndrome. In this population, coronary artery disease is by far the most common cause of sudden cardiac arrest, particularly in persons aged 35 and older.
Both the Brugada syndrome and the long QT syndrome are responsible for an irregular heart beat, which ultimately leads to a problem with cardiac arrest within the body. The condition known as cardiomyopathy leads to the development of an abnormally large heart muscle, which in turn leads to issues with cardiac arrest.
Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs – https://www.zionmarketresearch.com/sample/cardiac-arrest-treatment-market
(A free sample of this report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the Following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2023 updated report.
- The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
- About 228+ Pages Research Report (Including Recent Research)
- Provide detailed chapter-by-chapter guidance on Request
- Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2023
- Includes Tables and figures have been updated
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
- Zion Market Research research methodology
(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)
Global Cardiac Arrest Treatment Market: Growth Factors
The rise in the prevalence of cardiovascular diseases is expected to drive the expansion of the global market between 2023 and 2030.
The global market trends for cardiac arrest treatment will be boosted by an increase in cardiovascular illnesses caused by sedentary and inactive lifestyles, including employment that require sitting for long periods of time. For example, according to a research study that was released in 2021, atrial fibrillation is the most prevalent cardiac problem seen in patients. Ischemic stroke is a key risk factor caused by atrial fibrillation, therefore this finding is significant. This has led to a significant increase in the morbidity rate among patients and imposed a significant financial burden on the healthcare industries of a number of developing nations, which has led to an increase in the demand for the treatment of cardiovascular illnesses. The key forces behind the rise of the global market are an increase in the proportion of the population that is reaching retirement age as well as an uptick in the amount of money invested in research and development related to cardiovascular conditions. A rise in the amount of research conducted on the treatment of cardiac arrests would further expand the scope of the expansion of the global market. The demand in the worldwide market for drugs will continue to rise as new drugs enter the market. For instance, a significant Australian company known as Rapid Response Revival Research Limited produced CellAED in the United Kingdom during the first half of the year 2022.
Directly Purchase a copy of the report with TOC @ https://www.zionmarketresearch.com/buynow/su/cardiac-arrest-treatment-market
Report Scope
| Report Attribute | Details |
| Market Size in 2022 | USD 5 billion |
| Projected Market Size in 2030 | USD 8.3 billion |
| CAGR Growth Rate | 4.5% CAGR |
| Base Year | 2022 |
| Forecast Years | 2023-2030 |
| Key Market Players | Pfizer Inc., GE Healthcare, Novartis AG, Bayer AG, Boston Scientific Corporation, Amgen Inc., Abbott Laboratories, and others. |
| Key Segment | By Treatment, By Distribution Channel, and By Region |
| Major Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
| Purchase Options | Request customized purchase options to meet your research needs. Explore purchase options |
Cardiac Arrest Treatment Market: Segmentation Analysis
The global market for treatments for cardiac arrest can be broken down into three categories: treatment, distribution channel, and geography.
In terms of treatment, the global market for cardiac arrest treatment may be broken down into two distinct segments: medicines and medical devices. In addition, it is expected that the market category for medical devices, which accounted for about half of the total revenue share of the global market in 2022, will record the greatest CAGR over the course of the following years. Because defibrillators can transmit electric impulses to the heart, their increased use may be to blame for the expansion of this section in the evaluation timeline. Defibrillators are increasingly being used to bring back regular heartbeats. Additionally, the use of these medical devices can help prevent arrhythmias from occurring.
Hospitals, pharmacies, and other establishments make up some of the several components that make up the cardiac arrest treatment industry all around the world. In addition, it is anticipated that the hospitals segment would take the lead in the distribution channel segment over the next few years. In 2022, hospitals accounted for approximately 47% of the total revenue share of the global business. The expansion of the market throughout the period of analysis may be attributable to an increase in the total number of surgical procedures carried out in hospitals and clinics, which in turn generates a significant uptick in the demand for medical equipment at such facilities.
The global Cardiac Arrest Treatment market is segmented as follows:
By Treatment
- Drugs
- Vasopressors
- Anti-Arrhythmic Drugs
- Anticholinergic Drugs
- Corticosteroids
- Fibrinolytic Drugs
- Beta Blockers
- Others
- Medical devices
- Defibrillators
- Cardiac Resynchronization Therapy
- Others
By Distribution Channel
- Hospitals
- Pharmacies
- Others
Browse the full “Cardiac Arrest Treatment Market By Treatment (Drugs [Vasopressors, Anti-Arrhythmic Drugs, Anticholinergic Drugs, Corticosteroids, Fibrinolytic Drugs, Beta Blockers, And Others] And Medical Devices [Defibrillators, Cardiac Resynchronization Therapy, And Others)], By Distribution Channel (Hospitals, Pharmacies, And Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030″ Report At https://www.zionmarketresearch.com/report/cardiac-arrest-treatment-market
Competitive Landscape
Some of the main competitors dominating the global Cardiac Arrest Treatment market include –
- Pfizer Inc.
- GE Healthcare
- Novartis AG
- Bayer AG
- Boston Scientific Corporation
- Amgen Inc.
- Abbott Laboratories
Key Insights from Primary Research:
- According to the analysis shared by our research forecaster, the Cardiac Arrest Treatment market is likely to expand at a CAGR of around 4.5% during the forecast period (2023-2030).
- In terms of revenue, the Cardiac Arrest Treatment market size was valued at around US$ 5 billion in 2022 and is projected to reach US$ 8.3 billion by 2030.
- The global cardiac arrest treatment market is anticipated to grow rapidly over the forecast timeline owing to an increase in cardiovascular disorders caused due to sedentary & inactive lifestyles with sitting jobs.
- In terms of treatment, the medical devices segment is slated to register the highest CAGR over the analysis period.
- Based on distribution channel, the hospitals segment is expected to lead the segmental expansion over the projected timeframe.
- Region-wise, the Asia-Pacific cardiac arrest treatment industry is projected to register the fastest CAGR during the assessment timeline.
Have Any Query? Ask Our Experts: https://www.zionmarketresearch.com/inquiry/cardiac-arrest-treatment-market
Key questions answered in this report:
- What is the market size and growth rate forecast for Cardiac Arrest Treatment industry?
- What are the main driving factors propelling the Cardiac Arrest Treatment Market forward?
- What are the leading companies in the Cardiac Arrest Treatment Industry?
- What segments does the Cardiac Arrest Treatment Market cover?
- How can I receive a free copy of the Cardiac Arrest Treatment Market sample report and company profiles?
Key Offerings:
- Market Size & Forecast by Revenue | 2023−2030
- Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
- Market Segmentation – A detailed analysis By Treatment, By Distribution Channel, and By Region
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Request for Customization on this Report as per your requirements – https://www.zionmarketresearch.com/custom/4877
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)
Regional Analysis:
North America is projected to maintain global market dominance over the assessment timeline
North America, which contributed about 45% of the global cardiac arrest treatment market revenue in 2022, is predicted to lead the global market revenue in the ensuing years. The growth of the market in the region can be attributed to the rise in the rate of heart ailments witnessed in the adult population and the aging population in countries such as the U.S. and Canada. Presence of key players in these countries will drive the expansion of the market in the region.
Asia-Pacific cardiac arrest treatment industry is set to register the fastest CAGR in the upcoming years owing to a rise in the cases of heart disorders in densely populated countries such as India and China. Apart from this, a prominent rise in the use of medicines and medical equipment used for treating cardiac ailments will further embellish the growth of the market in the sub-continent.
By Region
- North America
- U.S.
- Canada
- Rest of North America
- Europe
- France
- UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
To know an additional revised 2023 list of market players, request a brochure of the report: https://www.zionmarketresearch.com/requestbrochure/cardiac-arrest-treatment-market
Browse Other Related Research Reports from Zion Market Research:
Vertical Axis Wind Turbine Market:: https://www.zionmarketresearch.com/report/vertical-axis-wind-turbine-market
Virtual Reality in Gaming Market:: https://www.zionmarketresearch.com/report/virtual-reality-in-gaming-market
Organic Coconut Water Market:: https://www.zionmarketresearch.com/report/organic-coconut-water-market
Precious Metals Market:: https://www.zionmarketresearch.com/report/precious-metals-market
VCSEL Market:: https://www.zionmarketresearch.com/report/vcsel-market
Voice Activated Transactions Market:: https://www.zionmarketresearch.com/report/voice-activated-transactions-market
Warehouse Automation Solutions Market:: https://www.zionmarketresearch.com/report/warehouse-automation-solutions-market
Home Ceiling Fan Market:: https://www.zionmarketresearch.com/report/u-s-home-ceiling-fan-market
Vegetarian Capsules Market:: https://www.zionmarketresearch.com/report/vegetarian-capsules-market
Water-Based Pigments Market:: https://www.zionmarketresearch.com/report/water-based-pigments-market
Water Leak Detection Systems Market:: https://www.zionmarketresearch.com/report/water-leak-detectio-systems-market
Women Health Therapeutics Market:: https://www.zionmarketresearch.com/report/women-health-therapeutics-market
Wireless Access Infrastructure Market:: https://www.zionmarketresearch.com/report/wireless-access-infrastructure-market
Business Intelligence Managed Services Market:: https://www.zionmarketresearch.com/report/business-intelligence-managed-services-market
Chemical Fiber Oil Market:: https://www.zionmarketresearch.com/report/chemical-fiber-oil-market
Smart Greenhouse Market:: https://www.zionmarketresearch.com/report/smart-greenhouse-market
Intelligent Irrigation Systems Market:: https://www.zionmarketresearch.com/report/intelligent-irrigation-systems-market
Contactless PoS Terminal Market:: https://www.zionmarketresearch.com/report/contactless-pos-terminal-market
LED Billboard Lights Market:: https://www.zionmarketresearch.com/report/led-billboard-lights-market
Cellular Concrete Market:: https://www.zionmarketresearch.com/report/cellular-concrete-market
About Zion Market Research:
Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us on LinkedIn: https://www.linkedin.com/company/zion-market-research/
Follow Us on Twitter: https://twitter.com/zion_research
Follow Us on Facebook: https://www.facebook.com/zionmarketresearch
Follow Us on Pinterest: https://www.pinterest.com/zionmarketresearch/
Follow Us on YouTube: https://youtu.be/Y0Yfi7N8zSs
Contact Us:
Rushikesh Dorge
USA: +1 347 690-0211
United Kingdom: +44 2032 894158
Japan: +81 50 5806 9039
India: +91 7768 006 007
Web: https://www.zionmarketresearch.com/
Blog: https://zmrblog.com/
Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?
Email Directly Here with Detail Information: sales@zionmarketresearch.com
- XRP Ledger Payment Volume Skyrockets Over 1,000%, Analysts Expect Similar For Remittix (RTX) - June 15, 2025
- Napco (NSSC) Under Scrutiny: Investor Suit and Sales Slump Shake Investor Confidence – Hagens Berman - June 15, 2025
- EGBN Investor News: If You Have Suffered Losses in Eagle Bancorp, Inc. (NASDAQ: EGBN), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - June 15, 2025
